United States · FDA National Drug Code directory
HYRIMOZ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61314-454_48b7e44a-945f-487d-b2fd-3da13d6d6fdb
- Product NDC
- 61314-454
- Form
- INJECTION, SOLUTION
- Composition / generic term
- adalimumab-adaz
- Labeler
- Sandoz Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230701
- Source listing expiry
- 20271231
Source-listed ingredients
- ADALIMUMAB — 80 mg/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (61314-454-20) / .8 mL in 1 SYRINGE · 61314-454-20
- 3 SYRINGE in 1 CARTON (61314-454-36) / .8 mL in 1 SYRINGE · 61314-454-36
- 3 SYRINGE, GLASS in 1 CARTON (61314-454-68) / .8 mL in 1 SYRINGE, GLASS · 61314-454-68
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →